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Abstract
Background: It has been proposed that anatomical differences in human and great ape guts arose in response to
species-specific diets and energy demands. To investigate functional genomic consequences of these differences,
we compared their physiological levels of phytanic acid, a branched chain fatty acid that can be derived from the
microbial degradation of chlorophyll in ruminant guts. Humans who accumulate large stores of phytanic acid
commonly develop cerebellar ataxia, peripheral polyneuropathy, and retinitis pigmentosa in addition to other
medical conditions. Furthermore, phytanic acid is an activator of the PPAR-alpha transcription factor that influences
the expression of genes relevant to lipid metabolism.
Results: Despite their trace dietary phytanic acid intake, all great ape species had elevated red blood cell (RBC)
phytanic acid levels relative to humans on diverse diets. Unlike humans, chimpanzees showed sexual dimorphism
in RBC phytanic acid levels, which were higher in males relative to females. Cultured skin fibroblasts from all
species had a robust capacity to degrade phytanic acid. We provide indirect evidence that great apes, in contrast
to humans, derive significant amounts of phytanic acid from the hindgut fermentation of plant materials. This
would represent a novel reduction of metabolic activity in humans relative to the great apes.
Conclusion: We identified differences in the physiological levels of phytanic acid in humans and great apes and
propose this is causally related to their gut anatomies and microbiomes. Phytanic acid levels could contribute to
cross-species and sex-specific differences in human and great ape transcriptomes, especially those related to lipid
metabolism. Based on the medical conditions caused by phytanic acid accumulation, we suggest that differences
in phytanic acid metabolism could influence the functions of human and great ape nervous, cardiovascular, and
skeletal systems.
Background
Humans and great apes (bonobos, chimpanzees, gorillas,
and orangutans) share a common gut anatomy, consist-
ing of a simple stomach, small intestine, small cecum
terminating in an appendix, and a hindgut consisting of
the large intestine, rectum, and anal canal [1]. Neverthe-
less, significant differences have been reported in their
gut proportions [2-4]. While the large intestine
represents the majority of the great ape gut volume, the
majority of the modern human gut volume consists of
the small intestine [2-4]. Initial surveys have also indi-
cated modern humans have a smaller total gut volume
to body mass ratio relative to the great apes [5-7]. How-
ever, this could be influenced by primate gut plasticity
related to diet and genetic diversity [2,8].
It has been proposed that gut proportions changed at
s o m ep o i n tw i t h i nt h eh u m a nl i n e a g ei nr e s p o n s et o
higher quality foods which can be digested in the small
intestine [2]. The diets of hominids and/or early human
populations improved, in part, due to cooking [9] and the
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through scavenging, hunting, fishing, and dairy consump-
tion [10-19]. In contrast, great ape species in the wild
derive a significant amount of their total daily metabolic
energy needs through the fermentation of lower quality
plant materials in their hindguts [20-25]. Although hind-
gut fermentation also occurs in humans [26-28], there is
evidence that wild great apes derive greater amount of
total daily metabolic energy from this process than do
humans on Western diets [20-22]. However, seasonal
changes in great ape diets and the limited dietary diver-
sity of the humans studied will influence the interpreta-
tion of these data sets.
To explore the systemic consequences of hindgut fer-
mentation activities in humans and great apes, we evalu-
ated their physiological levels and cellular metabolic
activities of phytanic acid, a branched chain fatty acid that
can bind to and/or activate PPAR-alpha [29-34] and RXR
[35-38] transcription factors. Humans do not synthesize
phytanic acid, but rather acquire it from the diet [39,40].
In ruminants, the gut fermentation of plant materials lib-
erates phytol, a constituent of chlorophyll, which is then
converted to phytanic acid and stored in fats [39,40].
While humans can covert free phytol into phytanic acid,
they do not accumulate significant amounts of phytanic
acid as a result of consuming plant materials [41,42]. How-
ever, they can obtain phytanic acid from ruminant fats,
fish, and dairy products [41]. Humans with impaired phy-
tanic acid catabolism can overaccumulate phytanic acid,
which results in peripheral polyneuropathy, cerebellar
ataxia, retinitis pigmentosa, anosmia, and hearing loss
[43-45]. This can also result in cardiac arrhythmias, shor-
tened metacarpals or metatarsals, and ichthyosis [43-45].
Despite the demonstrated importance of maintaining
appropriate levels of phytanic acid in humans and mice
[46-48], phytanic acid metabolism has not been studied
in the great apes. Based on the biochemical evaluation of
red blood cells and cultured primary skin fibroblasts, we
uncovered candidate human-specific differences in the
ability to obtain phytanic acid from dietary sources rela-
tive to the great apes. We also provide indirect evidence
that these changes could affect physiological functions
relevant to the evolution and health of these species.
Results
Red blood cell (RBC) phytanic acid levels
RBCs are commonly used to evaluate the physiological
abundance of phytanic acid (Fig. 1) in clinical settings
[49]. First, we measured RBC phytanic acid levels in a
cohort of humans with Western diets (N = 135), chim-
panzees (N = 46), bonobos (N = 4), lowland gorillas
(N = 7), and Sumatran orangutans (N = 3) (Fig. 2A and
Additional File 1). We found significant differences in
RBC phytanic acid levels in humans with Western diets
relative to the great apes (P <2 × 1 0
-13). Chimpanzee
(1.5-fold, P <3×1 0
-10), bonobo (1.7-fold, P <6×1 0
-3),
gorilla (1.7-fold, P <7×1 0
-4), and orangutan (2.6-fold,
P <4×1 0
-5) RBC phytanic acid levels were all elevated
relative to those of this human cohort. This is remark-
able given the higher phytanic acid content of human
Western diets, reportedly 50-100 mg per day [43], rela-
tive to the minimal (< 2 mg) daily amounts in the diets
of our great ape cohort, even taking nutritional biscuits
into consideration as described in the Materials and
Methods section.
To begin to address these dietary differences, we com-
pared RBC phytanic acid levels in great apes and humans
on phytanic acid-deficient diets (Fig. 2A). The latter are
based on a cohort of 16 humans on vegan diets for over
one year (Additional File 1). The absolute amount of phy-
tanic acid intake in this population is unknown; however,
Figure 1 Phytanic acid catabolism in mammals. Phytanic acid in
ruminant fats is derived from phytol produced during the bacterial
degradation of chlorophyll in their rumen (first stomach). After
conversion to its CoA thioester, phytanic acid undergoes a-
oxidation, yielding pristanic acid. This fatty acid then undergoes
three subsequent rounds of b-oxidation in the peroxisome. The
resulting medium chain fatty acid exits the peroxisome and
translocates to the mitochondrion where the remaining carbon
chain is degraded by b-oxidation. Abbreviations for the enzymes
listed include: HACL1 (aka HPCL2) = 2-hydroxyphytanoyl-CoA lyase;
PHYH = phytanoyl-CoA a-hydroxylase; PDH = pristanal
dehydrogenase, whose gene is not yet known. We note that
phytanic acid can also be degraded by b-oxidation; however, this
activity of this pathway is relatively minor [40,44].
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nents of vegan diets [41,50]. Phytanic acid RBC levels
were lower in vegans relative to individuals on Western
diets (2.3-fold, P <1×1 0
-13). We also found robust dif-
ferences in vegan RBC phytanic acid levels relative to the
great apes (P <3×1 0
-25). RBC phytanic acid levels in
chimpanzees (3.5-fold, P <6×1 0
-20), bonobos (3.9-fold,
P <6×1 0
-10), gorillas (3.8-fold, P <2×1 0
-12), and oran-
gutans (5.9-fold, P <5×1 0
-12) were all dramatically
higher relative to vegans.
Given the composition of our cohort, we had adequate
statistical power to screen for possible sexual dimorph-
ism in human (Western diet) and chimpanzee RBC phy-
tanic acid levels. Although no sex-specific differences
were found in humans on Western diets, male chimpan-
zees showed 1.4-fold higher (P <2×1 0
-6) RBC phytanic
acid levels relative to females (Fig. 2B). This occurs
despite the fact that our cohort of male and female
chimpanzees had equivalent dietary exposure to phyta-
nic acid and its precursor, phytol. Although our power
is limited due to the numbers of vegan males in our
cohort, there was also no evidence of sexual dimorphism
in vegan RBC phytanic acid levels (Fig. 2B).
Phytanic acid catabolism in cell culture
To evaluate cellular rates of phytanic acid metabolism,
we analyzed cultured human and great ape dermal fibro-
blasts (Additional File 2), which are routinely used for
the clinical diagnoses of phytanic acid and other peroxi-
somal disorders [43]. All fibroblast cultures showed
robust catabolism of phytanic acid and its metabolite
pristanic acid. Nevertheless, the oxidation rates of phyta-
nic acid (P = 0.010) and pristanic acid (P = 0.048) differed
in human relative to great ape cells (Fig. 3A-B). Human
cells showed elevated phytanic acid oxidation rates rela-
tive to gorilla (1.6-fold, P = 0.017) and orangutan (1.8-
fold, P = 0.002) cells (Fig. 3A). Humans cells also showed
elevated pristanic acid oxidation rates compared to chim-
panzee (1.7-fold, P = 0.018), bonobo (1.5-fold, P = 0.05),
and orangutan (1.8-fold, P = 0.011) cells (Fig. 3B).
Comparative transcriptome analysis of peroxisomal a-
and b-oxidation pathways
To evaluate potential in vivo consequences of cross-
species differences in lipid metabolism, we reanalyzed Figure 2 Phytanic acid levels in human and great ape red
blood cells. Box plots representing the percentage of phytanic acid
relative to total fatty acids from red blood cells are provided.
Median, quartile 1, quartile 3, minimum, and maximum values are
provided. In Panels A and B, the species (Hsa: human; Ptr:
chimpanzee; Ppa: bonobo; Ggo: gorilla; Ppy: orangutan), human diet
(V: vegan, W: western), and number of individuals successfully
analyzed is provided on the X-axes. Blood donor sex (M: male, F:
female) is provided in Panel B.
Figure 3 Phytanic acid catabolism in human and great ape
cultured fibroblasts. Box plots representing the relative rates of (A)
phytanic acid and (B) pristanic acid oxidation in cultured fibroblasts
are provided. Median, quartile 1, quartile 3, minimum, and
maximum values are provided. The species and number of samples
successfully analyzed is provided on the X-axis of both panels.
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5m a l ec h i m p a n z e ea n d6m a l eh u m a nl i v e r s ,b r a i n s ,
kidneys, heart, and testes [51]. We only considered data
from probes predicted to be perfectly matched to both
genomes and calculated gene expression scores only for
probe sets containing at least four probes after masking
[52]. We focused on genes involved in peroxisomal
phytanic acid a-oxidation, b-oxidation, and PPAR-
responsive genes relevant to phytanic acid metabolism
(Fig. 4, Additional File 3). Our criteria for differential
gene expression are provided in the legend of Figure 4.
We found that cross-species differential expression of
phytanic acid a-oxidation and peroxisomal b-oxidation
genes in the liver, brain, and testes always reflected
higher transcript levels in humans (Fig. 4). Genes in these
categories also showed cross-species differential expres-
sion in heart and kidney; however, some transcripts were
more abundant in humans (7 for heart and 4 for kidneys)
while others were more abundant in chimpanzees (1 for
heart and 8 for kidneys). Strikingly, ACOX3 transcript
levels were higher in humans relative to chimpanzees for
all five tissues examined. In 4 tissues (liver, heart, testes,
and kidney), PHYH transcript levels were also higher in
human relative to chimpanzee.T of u r t h e re x p l o r et h i s
latter observation, we measured PHYH levels in human,
chimpanzee, bonobo, and gorilla fibroblast cultures (6
different donors per species) via quantitative PCR (qPCR)
using primers designed against a conserved region of
this transcript. PHYH levels were at least 2-fold more
abundant in human relative to chimpanzee, bonobo, and
gorilla fibroblasts (P <3×1 0
-4 for each individual com-
parison, ANOVA P <2×1 0
-5 for human versus African
great apes).
Lastly, we examined a group of five genes (FABP1, DBI,
SLC27A1, GOT2,a n dCAT) previously used to evaluate
PPAR-activity in mice with phytanic acid disorders [53]
Figure 4 Differential expression of genes related to peroxisomal lipid metabolism. We reanalyzed of Affymetrix GeneChip U133v2.0
expression profiles of human and chimpanzee tissues [51] using the masking strategy stated in the text. We used standard F-tests (FDR-adjusted
using the Benjamini and Hochberg approach) to test for differences in the distributions by species for the 5 tissues. The fold change (FC) of
human (Hsa) versus chimpanzee (Ptr) geometric mean gene expression scores are provided. Differentially expressed genes (≥1.2 FC in either
direction with a Student’s t-test, two-tailed P-value ≤0.05 after Bonferroni correction) for a given tissue are highlighted in red (higher in human)
or green (higher in chimpanzee). Probe sets with (i) F-tests yielding a ≤5% FDR and (ii) differential expression in at least one tissue are shown.
All data are provided in Additional File 3.
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alpha [54]. All differentially expressed transcripts in heart
(DBI and SLC27A1)a n dt e s t e s( DBI and GOT2)w e r e
more abundant in humans. FABP1, DBI,a n dPEX11A
transcript levels were higher in human liver; however,
CAT transcripts were more abundant in chimpanzee
liver. None of these six genes showed cross-species differ-
ential expression in brain or kidney.
Discussion
Microbial fermentation in human [26-28] and great ape
[20-25] hindguts are responsible for the break down of
complex carbohydrates not processed and absorbed in
the small intestine. The major end products of hindgut
fermentation are short chain fatty acids, which provide
energy-yielding substrates for colonic mucosa that regu-
late its growth and blood flow and promotes sodium
and water absorption [26,27]. It has been estimated that
wild chimpanzees derive 21-33% and wild orangutans
derive 7-57% of their total daily metabolic energy from
fiber fermentation [22]. This could be as high as 30-60%
for wild Western gorillas [21]. In contrast, humans on
Western diets are estimated to obtain no more than
10% of their daily energy needs through hindgut fer-
mentation; however, this is likely higher in populations
with lower quality diets and instances of small intestinal
malabsorption [28].
Although we contrast human and the great ape dietary
strategies, it is important to consider diversity within the
great apes. For example, gorillas and orangutans can and
often do subsist on lower quality foods (e.g. mature foli-
age and unripe fruits) relative to chimpanzees and bono-
bos, which can consume ample amounts of succulent
ripe fruits [2]. Furthermore, chimpanzees hunt colobus
monkeys and other small mammals; however, this com-
prises a minor component of their diets and varies
among individuals and communities [55-59]. Thus, we
propose that it is likely that the human, chimpanzee,
bonobo, gorilla and orangutan lineages have all acquired
molecular adaptations relevant to their diets.
In the studies presented here, we began to evaluate
the broader systemic consequences of hindgut fermen-
tation and related lipid metabolic activity in humans
and great apes. In principle, RBC phytanic acid can be
an effective biomarker of hindgut fermentation of
plant materials as long as phytanic acid or its precur-
sor phytol is not appreciably present in the human or
great ape diets. The phytanic acid content of Western
diets (50-100 mg daily intake) [43] is estimated to be
at least 10 × greater than its free phytol content
[41,60]. Since phytanic acid is primarily found in rumi-
nant fats (organic beef fat has >325 mg/100 g), dairy
products (45% fat cream cheese has >125 mg/100 g),
and fish (canned salmon has >250 mg/100 g) [41],
human vegans are appropriate for our studies. In this
regard, a survey of fresh vegetables and fruits all
showed minimal phytol levels (≤2m gp h y t o l / 1 0 0g )
[41]. We also note a prior study demonstrating that an
individual who ingested 3.5-kg of boiled spinach leaves
within a 60 hour period as a supplement to an uncon-
trolled mixed diet later showed serum phytanic acid
levels within normal limits [42]. Our captive great ape
cohort should be exposed to similar low levels of diet-
a r yp h y t a n i ca c i d( <2m gd a i l yi n t a k e )a n dp h y t o l[ 4 1 ] .
We discovered elevated RBC phytanic acid levels in all
great apes relative to humans on both high- (Western)
and low-phytanic acid (vegan) diets (Fig. 2). In principle,
these could be influenced by differences in phytanic acid
retention and/or biosynthesis. Relevant to the retention
hypothesis, both humans and great apes showed robust
cellular rates of phytanic and pristanic acid oxidation
(Fig. 3). In fact, there were no differences in phytanic
acid oxidation rates in human relative to chimpanzee or
bonobo fibroblasts (Fig. 3A). Although it is possible that
the lower phytanic acid oxidation rates in gorilla and
orangutan relative to human fibroblasts (Fig. 3A) relate
to the dietary strategies of these species [2], these obser-
vations need to be validated in larger-scale studies prior
to commentary. We also cannot exclude the possibility
that the cultured fibroblasts do not fully reflect in vivo
activities; however, they are invaluable for the clinical
diagnosis of phytanic acid oxidation disorders [61]. Like-
wise, we cannot exclude the possibility that great apes,
unlike humans, show robust biological retention of trace
dietary phytanic acid. However, laboratory mice do not
accumulate significant physiological levels of phytanic
acid when fed standard diets not supplemented with
additional phytol or phytanic acid [53]. In addition, rats
on standard diets can rapidly catabolize artificially ele-
vated stores of phytanic acid in their tissues [62].
Our preferred hypothesis is that all the great apes,
unlike humans [45,63], are capable of accumulating
significant amounts of phytanic acid from the hindgut
fermentation of plant materials. We propose that the
great apes have maintained the ancestral condition and
that humans diverged since their most recent common
ancestor with chimpanzees and bonobos and now have a
derived metabolism. We believe that changes in gut anat-
omy provide a likely basis for the proposed reduction of
hindgut fermentation activity in the human lineage. In
this regard, it has been proposed that improved dietary
quality contributed to hindgut reduction in modern
humans relative to great apes (i.e. the hindgut comprises
~20% of the total human gut volume, but >50% of the
total great ape gut volume) [2,3] and the smaller total gut
volume to body mass ratio in modern humans relative to
great apes [6,7,64,65]. However, we also recognize that
the human and great ape gut microbiomes, whose
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and other environmental interactions [66,67], could also
contribute to the proposed differences in hindgut fer-
mentation activity. Thus, in principle, the improved diet-
ary quality in the human lineage could have influenced
the major factors (gut anatomy and microbial activities)
that we propose are most likely to be causally responsible
for the observed differences in human and great ape RBC
phytanic acid levels.
Given that sexual dimorphism in human lipid metabo-
lism is well-documented [68,69], we screened for sex-
specific differences in RBC phytanic acid levels. Here,
we found no evidence of sexual dimorphism in RBC
levels in humans on Western or vegan diets. However,
we observed 1.4-fold elevated RBC phytanic acid levels
in male relative to female chimpanzees (Fig. 2B). The
evolutionary implications and physiological origin of this
sexual dimorphism are unclear. Phytanic acid profiling
in additional males and females from other non-human
primates could shed light on the extent of this phenom-
enon. As discussed above, phytanic acid levels are
affected by multiple factors, including gut anatomies,
microbiomes, and gene expression, which provide candi-
date mechanisms for the observed sexual dimorphism in
chimpanzees.
We note that sexual dimorphism in phytanic acid meta-
bolism has been documented in rodents. C57BL/6J labora-
tory mice show sexually dimorphic phytanic acid
accumulation in response to phytol-enriched diets; how-
ever, unlike chimpanzees, females showed higher phytanic
acid levels than males [53,70]. There is no evidence as to
whether this is a metabolic adaptation to diet or a non-
specific result of inbreeding. It is thought this sexual
dimorphism is influenced by the higher liver expression of
sterol carrier protein-x (SCP-x) in males relative to females
[53]. SCP-x is required for branched chain fatty acid cata-
bolism through its keto-acyl CoA thiolase activity [53,70].
Sexual dimorphism in liver SCP-x expression has also
been observed in FVB mice [53], BALB/c mice [71], and
laboratory rats [72]. This suggests that sexual dimorphism
in phytanic acid metabolism could be present in additional
rodent species. To date, SCP-x expression has not been
measured in human and chimpanzee livers, even in a
recent study involving both sexes from each species [73].
We also investigated possible relationships between
human and chimpanzee RBC lipid profiles and their tran-
scriptomes. While there is no known physiological role
for phytanic acid, it can bind to and/or activate PPAR-
alpha [29-34], RXR [35-38], and likely other transcription
factors [29]. Experiments involving laboratory mice have
concluded that phytanic acid is a physiological ligand for
PPAR-alpha [29-31]. While the estimated phytanic acid
concentration in normal human serum (6 μM total [42],
2 μM free [35]) was at the threshold needed for RXR
stimulation of one cell culture study, the authors con-
cluded that phytol metabolites, such as phytanic acid, are
compelling candidate physiological effectors of RXR [35].
Here, we found that multiple genes reported to be influ-
enced by PPAR-alpha activity, including those involved in
peroxisomal a-a n db-oxidation of fatty acids, show cross-
species expression differences in the chimpanzee and
human tissues surveyed (Fig. 4). Such genes were primarily
more highly expressed in humans relative to chimpanzee
for all tissues except kidney, where higher expression in
chimpanzees was frequently found. Exploratory work, not
involving non-human primates, highlighted the lower fatty
acid a-oxidation capacity in the kidneys, but not livers, of
carnivorous relative to herbivorous animals [74]. Also of
interest, others have provided gene expression-based evi-
dence that PPAR-signaling is higher in human relative to
chimpanzee liver [75]. The elevated FABP1 transcript
levels in human liver suggests an increased capacity for
humans to transport phytanic acid to peroxisomes for
degradation [53]. Nevertheless, we recognize phytanic acid
is just one of several activators of PPAR transcription fac-
tors and that the dietary information and RBC lipid pro-
files of the humans and chimpanzees in the gene
expression profiling studies are unknown.
We have previously noted that the toxicity associated
with abnormal phytanic acid accumulation in humans
could provide selective pressure to maintain or enhance
its degradation [76]. For example, Refsum disease is an
autosomal recessive disorder in humans that can result
from mutations in the PHYH gene and subsequent accu-
mulation of phytanic acid in tissues [46,47]. This typically
affects the peripheral nerves (i.e. polyperipheral neuropa-
thy), movement (i.e. cerebellar ataxia), and senses (e.g. reti-
nitis pigmentosa, anosmia, and hearing loss) [43-45].
These individuals can also show cardiac arrhythmias, ske-
letal malformations (e.g. shortened metacarpals or meta-
tarsals), and skin changes (i.e. ichthyosis) [43-45]. Given
that cardiac arrhythmias are suspected to be responsible
for the sudden deaths of Refsum disease patients [43], the
commonly observed sudden cardiac death, presumed sec-
ondary to fatal arrhythmias, in captive male chimpanzees
[77] could be influenced by their physiological levels of
phytanic acid. However, the RBC phytanic acid levels in
our cohort of male chimpanzees are far below those of
Refsum disease patients, which was approximately 100
times higher than normal in one case we evaluated. Never-
theless, we raise the possibility that phytanic acid metabo-
lism could influence physiological differences and medical
conditions amongst human and non-human primates.
Conclusions
The candidate differences in human and great ape phyta-
nic acid metabolism are consistent with prior reports
that the regulation of genes involved in lipid metabolism
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and that the promoter regions of nutrition-related genes
are under positive selection in humans [78]. It is also
relevant that the effects human diets have on mouse liver
transcriptomes can be used as a model for expression dif-
ferences between humans and chimpanzees [79]. We
note that even if transcriptome data of humans and
chimpanzees on matching diets were obtained, differ-
ences in how each species digests their food and extract
regulators of transcription would have a major impact on
the observed cross-species and sex-specific differences.
Our study also relates to hypotheses that historic diets
and/or changes in lipid metabolism influenced the evolu-
tion of numerous human traits [2,12,18,55,64,65,80-85].
To further explore such hypotheses, it will be necessary to
determine if the RBC phytanic acid profiles in our cohort
extend to other cell types. The comparative analyses of the
lipid composition of human and great ape nervous and
cardiovascular systems will be of special interest given the
clinical phenotypes observed in humans with phytanic
acid metabolic [43-45] and other peroxisomal disorders
[86]. In addition, prostate tissue could be of interest given
the differences of phytanic acid metabolic activities in nor-
mal and cancerous tissues [87-89] and male reproductive
differences across human and non-human primates [90].
Lastly, we propose that larger-scale lipid profiling studies
will likely identify additional candidate metabolic adapta-
tions to human and non-human diets and that investiga-
tions into the microbial contributions toward specific
metabolic differences is warranted.
Methods
Cohort for red blood cell lipid profiling
Bloods from adult humans with Western diets were col-
lected from healthy individuals attending an international
conference. Bloods from adult humans on vegan diets for
over one year were collected in conjunction with a blood
donor center. Appropriate Institutional Review Board
(IRB) approval from the University of Southern California
and Johns Hopkins Medicine was obtained for all human
subjects research. Chimpanzee blood was collected at the
Alamogordo Primate Facility. All chimpanzees took part
in daily enrichment activities to maintain psychological
well-being. Animals were maintained in accordance with
the Guide for the Care and Use of Animals (U.S. Dept. of
Health and Human Services, Public Health Service,
Bethesda, MD., 1996). The APF and its program were fully
accredited by the Association for Assessment and Accredi-
tation of Laboratory Animal Care, International (AAA-
LAC). Other great ape bloods were collected at the
Zoological Society of San Diego. The gender and ages of
blood donors are provided in Additional File 2. One gorilla
blood donor, described in reference [91], carries a deletion
of the distal q arm of chromosome 3 (the homolog of
human chromosome 4) as indicated in Additional File 4.
Great ape diets contain fresh fruits, vegetables, and nutri-
tional biscuits. Capillary gas chromatography (GC) - elec-
tron-capture negative-ion mass spectrometry [92] analysis
of nutritional biscuits indicated the great apes were
exposed to <2 mg of daily phytanic acid intake.
Red blood cell lipid profiling
Whole blood samples were collected from fasting indivi-
duals and stored in EDTA blood collection tubes. RBCs
were collected by centrifugation, washed twice with phy-
siological saline, transferred to freezer vials, flushed with
nitrogen, and stored at -80°C until analysis. RBCs were
thawed briefly before 100 μl aliquots were taken for ana-
lysis of the total lipid fatty acid content by capillary GC
- electron-capture negative-ion mass spectrometry [92].
Processed data are provided in Additional File 4.
Primary fibroblast cultures
Great ape dermal fibroblasts were obtained from the
Zoological Society of San Diego while human dermal
fibroblasts were obtained from the Coriell Institute for
Medical Research or the Kennedy Krieger Institute. All
individuals are thought to be unrelated. The gender, age,
and biopsy site of all fibroblast donors and corresponding
biochemical analyses are provided in Additional File 2.
Fibroblasts were cultured as previously described [76].
Phytanic and pristanic acid oxidation in cultured
fibroblasts
Fatty acids were dried under nitrogen and solubilized with
b-cyclodextrin (Sigma; 10 mg/ml in 10 mM Tris, pH 7.5)
by warming to 37°C and sonication. Fibroblasts were
grown to approximately 80% confluence in 12-well culture
plates under standard conditions. Afterwards, the media
was removed and replaced with 0.6 mL of serum-free cul-
ture media supplemented with 10 μM[ 1 -
14C]-phytanic
acid (~40,000 dpm/nmol) or 10 μM [1-
14C]-pristanic acid
(~20,000 dpm/nmol). The cells were incubated for two
hours (pristanic) or four hours (phytanic) at 37°C in 5%
CO2. Reactions were terminated by addition of 0.12 ml of
2.6 N HClO4. Water-soluble reaction products were sepa-
rated from the labeled substrates and quantified by liquid
scintillation counting. The specific activity of phytanic acid
or pristanic acid oxidation (pmoles/hour/mg protein) were
calculated based on the amount of water-soluble radioac-
tivity in the test sample minus the blank per mg of protein,
determined using the Lowry method [93]. All primary data
are provided in Additional File 5.
Statistical considerations
We analyzed all data on the log2 scale. We used analysis
of variance (ANOVA) to compare average blood lipid
data across humans and great apes. Heterogeneity
Watkins et al. BMC Physiology 2010, 10:19
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Page 7 of 10P-values are reported for the test that the mean level is
different in at least one of the great apes groups, and
Wald P- v a l u e sf o rt e s t sc o m p a r i n gt h ea v e r a g el e v e li n
individual non-human primate groups to humans.
Under ANOVA, statistical tests use an estimate of
within-group variation from all samples. Due to the
unbalanced group sizes, this estimate is driven by the
variation in humans and in chimpanzees. For gene
expression studies, we tested for differential expression
(Fig. 4) using ANOVA and standard F-tests. To account
for testing differential expression across multiple genes,
we adjusted p-values using the Benjamini and Hochberg
approach for controlling the false-discovery rate (FDR).
All analyses were done using the R programming
language.
Additional material
Additional file 1: Composition of blood donor cohort. A summary of
the numbers, ages, and sex of blood donors is provided.
Additional file 2: Skin fibroblast cultures used for phytanic and
pristanic acid biochemical analysis. A summary of donor sex and age
and anatomical source of the skin fibroblasts is provided.
Additional file 3: Detailed summary of gene expression data for
cross-species comparisons. More complete gene expression data
summary statistics relevant to Figure 4 are provided.
Additional file 4: Phytanic acid levels relative to total fatty acids in
red blood cells from individual donors. Relative phytanic acid levels
for all RBC donors are provided.
Additional file 5: Rates of phytanic and pristanic acid oxidation in
cultured dermal fibroblasts. The rates of phytanic and pristanic acid
oxidation from all individual fibroblast cultures are provided.
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